These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27326337)

  • 21. Synthesis and biological evaluation of novel N
    Nirogi RV; Bandyala TR; Gangadasari PR; Khagga M
    J Enzyme Inhib Med Chem; 2016; 31(sup1):1-15. PubMed ID: 27806648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Phenyl-1
    Drop M; Canale V; Chaumont-Dubel S; Kurczab R; Satała G; Bantreil X; Walczak M; Koczurkiewicz-Adamczyk P; Latacz G; Gwizdak A; Krawczyk M; Gołębiowska J; Grychowska K; Bojarski AJ; Nikiforuk A; Subra G; Martinez J; Pawłowski M; Popik P; Marin P; Lamaty F; Zajdel P
    ACS Chem Neurosci; 2021 Apr; 12(7):1228-1240. PubMed ID: 33705101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HT
    Yi C; Xue Y; Chen K; Wang T; Yu J; Wang Z; Jin C
    Bioorg Med Chem; 2022 Sep; 70():116917. PubMed ID: 35839536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT
    Yi C; Chen K; Liang H; Wang Z; Wang T; Li K; Yu J; Sun J; Jin C
    Bioorg Med Chem; 2022 Oct; 71():116950. PubMed ID: 35926324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Marć MA; Satała G; Wilczyńska D; Kotańska M; Więcek M; Kamińska K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An exit beyond the pharmacophore model for 5-HT
    Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J
    Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
    Arnt J; Bang-Andersen B; Grayson B; Bymaster FP; Cohen MP; DeLapp NW; Giethlen B; Kreilgaard M; McKinzie DL; Neill JC; Nelson DL; Nielsen SM; Poulsen MN; Schaus JM; Witten LM
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1021-33. PubMed ID: 20569520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats.
    Bokare AM; Bhonde M; Goel R; Nayak Y
    Psychopharmacology (Berl); 2018 May; 235(5):1557-1570. PubMed ID: 29502275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
    Mattsson C; Sonesson C; Sandahl A; Greiner HE; Gassen M; Plaschke J; Leibrock J; Böttcher H
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4230-4. PubMed ID: 16055331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease.
    Hirano K; Piers TM; Searle KL; Miller ND; Rutter AR; Chapman PF
    Life Sci; 2009 Apr; 84(15-16):558-62. PubMed ID: 19302808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands.
    Nirogi RV; Kothmirkar P; Kambhampati R; Konda JB; Arepalli S; Pamuleti NG; Deshpande AD; Bandyala T; Shinde AK; Dubey PK
    ACS Med Chem Lett; 2010 Oct; 1(7):340-4. PubMed ID: 24900216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study into a possible mechanism responsible for the antidepressant-like activity of the selective 5-HT6 receptor antagonist SB-399885 in rats.
    Wesołowska A
    Pharmacol Rep; 2007; 59(6):664-71. PubMed ID: 18195455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists.
    Nirogi RV; Bandyala TR; Reballi V; Konda JB; Daulatabad AV; Khagga M
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):85-97. PubMed ID: 24666297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
    Wesołowska A
    Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.